TORONTO, ONTARIO — (Marketwire) — 08/19/11 — Medifocus Inc. (Medifocus or the Company) (TSX VENTURE: MFS)(OTCQX: MDFZF) announces that it has filed today its Financial Statements for the year ended March 31, 2011, related Management-s Discussion and Analysis and other related annual filings. These documents will be available for consultation under the Company-s profile on SEDAR at .
Medifocus will apply for the revocation of the cease trade orders respectively issued by the Ontario Securities Commission on August 16, 2011 and the British Columbia Securities Commission on August 9, 2011. The Company will also apply to the TSX Venture Exchange for trading of its common shares to be reinstated. Medifocus also confirms that there is no undisclosed material change or material fact respecting its affairs.
About Medifocus Inc.
Medifocus owns a patented microwave focusing technology platform (the Adaptive Phased Array (APA) technology), which can precisely target and control microwave energy to cause heating in cancerous tumors anywhere in the body reliably and repeatedly. The ability to target tumors with a precision controlled dose of heat can be used to destroy tumors at higher temperatures, to treat tumors in combination with chemotherapy and/or radiation at moderate temperatures for increased effectiveness and reduced toxicity and to trigger the targeted release of therapeutic drugs and genes at tumor sites at lower temperatures. While the core technology has been licensed from the Massachusetts Institute of Technology, Medifocus has further refined the precision of the microwave focusing and control ability and developed a commercial system dedicated exclusively for the treatment of Breast Cancer. Please visit for more details.
Forward-Looking Statements and Information
This news release contains forward-looking statements, which may not be based on historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. Except as required under applicable securities laws, the Company disclaims any obligation to update any such factors or to publicly announce the results of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Medifocus Inc.
John Mon
(410) 290-5734
You must be logged in to post a comment Login